1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict 28
2.1.4 Impact of Israel-Palestine War 30
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 43
3 Segmentation of Global Market by Therapy 47
3.1 Market Overview by Therapy 47
3.2 Tissue-based Therapy 50
3.3 Gene-based Therapy 51
3.4 Cell-based Therapy 52
3.5 Small Molecule & Biologic 53
4 Segmentation of Global Market by Material 54
4.1 Market Overview by Material 54
4.2 Synthetic Material 57
4.3 Biologically Derived Material 58
4.4 Genetically Engineered Material 59
4.5 Other Materials 60
5 Segmentation of Global Market by Application 61
5.1 Market Overview by Application 61
5.2 Oncology 64
5.3 Musculoskeletal 65
5.4 Dermatology & Wound Care 66
5.5 Immunology and Inflammation 67
5.6 Cardiovascular Diseases 68
5.7 Ophthalmology 69
5.8 Other Applications 70
6 Segmentation of Global Market by End User 71
6.1 Market Overview by End User 71
6.2 Hospitals & Clinics 74
6.3 Ambulatory Surgical Centers 75
6.4 Other End Users 76
7 Segmentation of Global Market by Region 77
7.1 Geographic Market Overview 2023-2033 77
7.2 North America Market 2023-2033 by Country 82
7.2.1 Overview of North America Market 82
7.2.2 U.S. 86
7.2.3 Canada 89
7.2.4 Mexico 91
7.3 European Market 2023-2033 by Country 93
7.3.1 Overview of European Market 93
7.3.2 Germany 97
7.3.3 U.K. 99
7.3.4 France 101
7.3.5 Spain 103
7.3.6 Italy 105
7.3.7 Russia 107
7.3.8 Rest of European Market 109
7.4 Asia-Pacific Market 2023-2033 by Country 111
7.4.1 Overview of Asia-Pacific Market 111
7.4.2 Japan 115
7.4.3 China 118
7.4.4 Australia 120
7.4.5 India 122
7.4.6 South Korea 124
7.4.7 Rest of APAC Region 126
7.5 South America Market 2023-2033 by Country 128
7.5.1 Argentina 132
7.5.2 Brazil 134
7.5.3 Chile 136
7.5.4 Rest of South America Market 138
7.6 MEA Market 2023-2033 by Country 139
7.6.1 UAE 143
7.6.2 Saudi Arabia 145
7.6.3 South Africa 147
7.6.4 Other National Markets 149
8 Competitive Landscape 150
8.1 Overview of Key Vendors 150
8.2 New Product Launch, Partnership, Investment, and M&A 153
8.3 Company Profiles 154
AbbVie Inc. 154
Amgen, Inc. 156
AstraZeneca plc 157
Baxter International Inc. 158
Bayer AG 159
Becton Dickinson and Company 160
Bristol-Myers Squibb Company 161
Cook Biotech Inc. 162
F. Hoffmann La Roche Ltd. 163
Gilead Sciences, Inc. 164
GlaxoSmithKline (GSK) 165
Integra Lifesciences Corp. 166
Medtronic PLC 167
Merck KgaA 168
Mimedx Group, Inc. 169
Novartis AG 170
Organogenesis Inc. 171
Smith and Nephew plc 172
Takeda Pharmaceutical Company Limited 173
Thermo Fisher Scientific Inc. 174
Vericel Corporation 175
9 Investing in Regenerative Medicine Industry: Risk Assessment and Management 176
9.1 Risk Evaluation of Global Market 176
9.2 Critical Success Factors (CSFs) 183
RELATED REPORTS 186